Measles in Czech population with varying vaccination rates in 2018–2019: clinical and laboratory differences between vaccinated and unvaccinated individuals and their relevance to clinical practice

References

• Moss WJ. Measles. Lancet. 2017;390(10111):2490–2502. doi: 10.1016/S0140-6736(17)31463-0.
   PubMed Web of Science ®Google Scholar
• Facchin G, Bella A, Del Manso M, et al. Decline in reported measles cases in Italy in the COVID-19 era, January 2020 – July 2022: the need to prevent a resurgence upon lifting non-pharmaceutical pandemic measures. Vaccine. 2023;41(7):1286–1289. doi: 10.1016/j.vaccine.2023.01.021.
   PubMed Web of Science ®Google Scholar
• Nicolay N, Mirinaviciute G, Mollet T, et al. Epidemiology of measles during the COVID-19 pandemic, a description of the surveillance data, 29 EU/EEA countries and the United Kingdom, January to May 2020. Euro Surveill. 2020;25(31):2001390. doi: 10.2807/1560-7917.ES.2020.25.31.2001390.
   PubMedGoogle Scholar
• ECDC. European centre for disease prevention and control.measles. Annual Epidemiological Report for 2022. [cited 2023 August 18]. Available from: https://www.ecdc.europa.eu/en/publications-data/measles-annual-epidemiological-report-2022.
   Google Scholar
• Ji C, Piché-Renaud P-P, Apajee J, et al. Impact of the COVID-19 pandemic on routine immunization coverage in children under 2 years old in Ontario, Canada: a retrospective cohort study. Vaccine. 2022;40(12):1790–1798. doi: 10.1016/j.vaccine.2022.02.008.
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Medic S, Cassimos DC, et al. Decreasing routine vaccination rates in children in the COVID-19 era. Vaccine. 2022;40(18):2525–2527. doi: 10.1016/j.vaccine.2022.03.033.
   PubMed Web of Science ®Google Scholar
• Drenjancevic I, Samardžić S, Stupin A, et al. Measles vaccination and outbreaks in Croatia from 2001 to 2019; a comparative study to other European countries. Int J Environ Res Public Health. 2022;19(7):4140. doi: 10.3390/ijerph19074140
   PubMed Web of Science ®Google Scholar
• WHO. World Health Organization. Measles vaccination coverage. Available from: https://immunizationdata.who.int/pages/coverage/MCV.html?CODE=CZE&ANTIGEN=MCV1&YEAR=. 2023.
   Google Scholar
• Dixon MG, Ferrari M, Antoni S, et al. Progress toward regional measles elimination - worldwide, 2000–2020. MMWR Morb Mortal Wkly Rep. 2021;70(45):1563–1569. doi: 10.15585/mmwr.mm7045a1.
   PubMed Web of Science ®Google Scholar
• Limberkova R, et al. Measles outbreaks in 2017–2019 – molecular surveillance started in the Czech Republic. Epidemiol Mikrobiol Imunol. 2022;71(1):40–47.
   PubMed Web of Science ®Google Scholar
• WHO. Measles outbreaks strategic response plan 2021–2023. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO. 2021. Available from: https://www.who.int/publications/i/item/9789240018600.
   Google Scholar
• Choe YJ, Hu JK, Song KM, et al. Evaluation of an expanded case definition for vaccine-modified measles in a school outbreak in South Korea in 2010. Jpn J Infect Dis. 2012;65(5):371–375. doi: 10.7883/yoken.65.371.
   PubMed Web of Science ®Google Scholar
• Moss WJ, Cutts F, Griffin DE. Implications of the human immunodeficiency virus epidemic for control and eradication of measles. Clin Infect Dis. 1999;29(1):106–112. doi: 10.1086/520136.
   PubMed Web of Science ®Google Scholar
• Morley D. Severe measles in the tropics. I. Br Med J. 1969;1(5639):297–300. doi: 10.1136/bmj.1.5639.297.
   PubMedGoogle Scholar
• Stein-Zamir C, Shoob H, Abramson D. Measles clinical presentation, hospitalization and vaccination status among children in a community-wide outbreak. Vaccine. 2023;41(17):2764–2768. doi: 10.1016/j.vaccine.2023.03.043.
   PubMed Web of Science ®Google Scholar
• Hübschen JM, Gouandjika-Vasilache I, Dina J. Measles. Lancet. 2022;399(10325):678–690. doi: 10.1016/S0140-6736(21)02004-3.
   PubMed Web of Science ®Google Scholar
• López-Perea N, Fernández-García A, Echevarría JE, et al. Measles in vaccinated people: epidemiology and challenges in surveillance and diagnosis in the post-elimination phase. Spain, 2014-2020. Viruses. 2021;13(10):1982. doi: 10.3390/v13101982.
   PubMed Web of Science ®Google Scholar
• van Dam ASG, Woudenberg T, de Melker HE, et al. Effect of vaccination on severity and infectiousness of measles during an outbreak in The Netherlands, 2013–2014. Epidemiol Infect. 2020;148:e81. doi: 10.1017/S0950268820000692.
   PubMed Web of Science ®Google Scholar
• Castro-Silva R, Camacho LAB, Amorim L, et al. Serological surveillance of measles in blood donors in Rio De Janeiro, Brazil. Rev Panam Salud Publica. 2003;14(5):334–340. doi: 10.1590/s1020-49892003001000008.
   PubMedGoogle Scholar
• Lengyel G, Marossy A, Ánosi N, et al. Screening of more than 2000 Hungarian healthcare workers’ anti-measles antibody level: results and possible population-level consequences. Epidemiol Infect. 2018;147:e7. doi: 10.1017/S0950268818002571.
   PubMed Web of Science ®Google Scholar
• Díaz Ortega JL, Castaneda D, Arellano Quintanilla DM, et al. Antibody persistence in children aged 6–7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection. Vaccine. 2017;35(23):3116–3122. doi: 10.1016/j.vaccine.2017.04.027.
   PubMed Web of Science ®Google Scholar
• Song K, Lee JM, Lee EJ, et al. Control of a nosocomial measles outbreak among previously vaccinated adults in a population with high vaccine coverage: Korea, 2019. Eur J Clin Microbiol Infect Dis. 2022;41(3):455–466. doi: 10.1007/s10096-021-04390-4.
   PubMed Web of Science ®Google Scholar
• Hickman CJ, Hyde TB, Sowers SB, et al. Laboratory characterization of measles virus infection in previously vaccinated and unvaccinated individuals. J Infect Dis. 2011;204(Suppl 1):S549–S58. doi: 10.1093/infdis/jir106.
   PubMedGoogle Scholar
• Hahné SJM, Nic Lochlainn LM, van Burgel ND, et al. Measles outbreak among previously immunized healthcare workers, The Netherlands, 2014. J Infect Dis. 2016;214(12):1980–1986. doi: 10.1093/infdis/jiw480.
   PubMed Web of Science ®Google Scholar
• Cherry JD, Zahn M. Clinical characteristics of measles in previously vaccinated and unvaccinated patients in California. Clin Infect Dis. 2018;67(9):1315–1319. doi: 10.1093/cid/ciy286.
   PubMed Web of Science ®Google Scholar
• Bianchi S, Gori M, Fappani C, et al. Characterization of vaccine breakthrough cases during measles outbreaks in Milan and surrounding areas, Italy, 2017–2021. Viruses. 2022;14(5):1068. doi: 10.3390/v14051068.
   PubMed Web of Science ®Google Scholar
• Trabucco Aurilio M, Iannuzzi I, Di Giampaolo L, et al. A cross-sectional serological study for measles among Italian medical students in 2020. TOPHJ. 2021;14(1):239–239. doi: 10.2174/1874944502114010239.
   Web of Science ®Google Scholar
• Malinova J, Petras M, Celko AM. A serosurvey identifying vulnerability to measles in health care workers. A hospital-based prospective seroprevalence study. Int J Environ Res Public Health. 2020;17(12):4219. doi: 10.3390/ijerph17124219.
   PubMed Web of Science ®Google Scholar
• Sa Machado R, Perez Duque M, Almeida S, et al. Measles outbreak in a tertiary level hospital, Porto, Portugal, 2018: challenges in the post-elimination era. Euro Surveill. 2018;23(20):18–00224. doi: 10.2807/1560-7917.ES.2018.23.20.18-00224.
   PubMedGoogle Scholar
• Augusto GF, Cruz D, Silva A, et al. Challenging measles case definition: three measles outbreaks in three health regions of Portugal, February to April 2018. Euro Surveill. 2018;23(28):1800328. doi: 10.2807/1560-7917.ES.2018.23.28.1800328.
   Google Scholar
• Arima Y, Oishi K. Letter to the editor: measles cases among fully vaccinated persons. Euro Surveill. 2018;23(34):1800449. doi: 10.2807/1560-7917.ES.2018.23.34.1800449.
   PubMedGoogle Scholar
• Kurata T, Kaida Y, Kanbayashi D, et al. Achieving measles elimination and emerging modified measles: longitudinal measles epidemiology from 1982 to 2021 in Osaka prefecture, Japan. Vaccine. 2023;42(2):271–286. doi: 10.1016/j.vaccine.2023.12.004.
   PubMed Web of Science ®Google Scholar
• Kohnen M, Hoffmann P, Frisch C, et al. Diagnostic challenges and pockets of susceptibility identified during a measles outbreak, Luxembourg, 2019. Euro Surveill. 2021;26(22):2000012. doi: 10.2807/1560-7917.ES.2021.26.22.2000012.
   Google Scholar
• Sundell N, et al. Measles outbreak in Gothenburg urban area, Sweden, 2017 to 2018: low viral load in breakthrough infections. Euro Surveill. 2019;24(17):1900114. doi: 10.2807/1560-7917.ES.2019.24.17.1900114.
   Google Scholar
• Sowers SB, Rota JS, Hickman CJ, et al. High concentrations of measles neutralizing antibodies and high-avidity measles IgG accurately identify measles reinfection cases. Clin Vaccine Immunol. 2016;23(8):707–716. doi: 10.1128/CVI.00268-16.
   PubMed Web of Science ®Google Scholar